<DOC>
	<DOC>NCT01445626</DOC>
	<brief_summary>This study will use retrospective data to evaluate the efficacy, safety, and re-injection interval of OZURDEX速 in the treatment of macular oedema due to Retinal Vein Occlusion (RVO).</brief_summary>
	<brief_title>A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex速) for Macular Oedema Due to Retinal Vein Occlusion (RVO)</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Macular oedema in the study eye due to BRVO or CRVO Received at least 2 OZURDEX速 injections in the study eye Received OZURDEX速 injections as part of or during any clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>